Key facts
- It has raised $23.3M across 1 recorded rounds; the latest was Accelerator/Incubator in Jan 2020.
- Notable investors include Alumni Ventures, Springboard Enterprises, Wing Venture Capital, Band of Angels, HearstLab — 12 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Strategikon
Funding rounds
1 roundsAbout Strategikon
Operator of a cloud-based platform intended to cater to the needs of business management of pharmaceutical clinical trials. The company's platform offers planning, outsourcing, and financial and contract management of clinical trials, enabling businesses to generate insights and analytics into their clinical portfolios and providers' performance.
- Industry
- Other Pharmaceuticals and Biotechnology
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 35
- Website
- strategikon.com/
- Ownership
- Privately Held (backing)
Strategikon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Strategikon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Strategikon in its N-PORT filings yet. We sweep new filings monthly.